Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Potent and selective iNOS inhibitor disclosed by Merck & Co.

April 29, 1997

Genelabs reports preliminary results from phase III trial of GL-701 for lupus

April 28, 1997

Antiarthritic activity and mechanism of action of mercaptoethylguanidine

April 25, 1997

Signal describes agents that block transcription factor activation

April 24, 1997

Phase III results for TS-110 in osteoarthritis

April 23, 1997

Caspase-1 involved in the regulation of multiple cytokines

April 21, 1997

Royce Laboratories' generic antiinflammatory approved by FDA

April 18, 1997

New MMP inhibitor disclosed by Agouron

April 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...